advisorsecurities master

KPTIKaryopharm Therapeutics Inc.

CSNasdaq (XNAS)·USD

Identity

Security key
17809
Ticker
KPTI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2013-11-06
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
KPTI

Detail

Enriched 2026-08-14 20:47

Market cap
$46,005,774.29
Shares outstanding (class)
22,662,943
Shares outstanding (weighted)
22,662,943
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
228
Location
NEWTON, MA
Description

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data